Successful management of pre-existing psoriatic arthritis through targeting the IL-23/IL-17 axis in cancer patients receiving immune checkpoint inhibitor therapy: a case series.
Yuanteng Jeff LiPavlos MsaouelMatthew CampbellPatrick HwuAdi DiabSang T KimPublished in: RMD open (2024)
These three cases suggest that targeting the IL-17/23 axis may be an effective and safe approach for patients with cancer and pre-existing PsA being considered for ICI therapy.